These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 648109)
41. [Report of experiences with ambulatory cytostatic chemotherapy in germinal testicular tumors and metastasizing renal carcinomas]. Schulz R; Vogler H Z Urol Nephrol; 1981 Jan; 74(1):21-33. PubMed ID: 7195123 [TBL] [Abstract][Full Text] [Related]
42. [Chemotherapy of malignant neoplasms in children]. Bukhny AF; Zikiriakhodzhaev DZ Med Sestra; 1986 Mar; 45(3):42-4. PubMed ID: 3636563 [No Abstract] [Full Text] [Related]
43. [Responsibility of nursing personnel in the use of cytostatic therapy. 8 characteristics for holistic care of tumor patients]. Bachmann-Mettler I Krankenpfl Soins Infirm; 1983 Oct; 76(10):21-5. PubMed ID: 6317942 [No Abstract] [Full Text] [Related]
44. Experience with an implantable venous access system for chemotherapy. Pettengell R; Davies AJ; Harvey VJ N Z Med J; 1991 Jul; 104(915):284-5. PubMed ID: 1852329 [TBL] [Abstract][Full Text] [Related]
45. [Implantable systems for the treatment of cancer--ambulatory chemotherapy: an advantage for the patient]. Pozzi E Krankenpfl Soins Infirm; 1991 Jan; 84(1):71-3. PubMed ID: 1994113 [No Abstract] [Full Text] [Related]
46. Options for venous access in ambulatory care: issues in selection and management. Herbst SL J Infus Chemother; 1996; 6(4):186-94. PubMed ID: 9229314 [TBL] [Abstract][Full Text] [Related]
47. Successful chemotherapy: quality care for the cancer patient. Law D Can Nurse; 1980 Feb; 76(2):19-22. PubMed ID: 6898165 [No Abstract] [Full Text] [Related]
48. New approach allows high-dose chemotherapy to be given entirely on an outpatient basis. Oncology (Williston Park); 1996 Feb; 10(2):221-2. PubMed ID: 8838265 [No Abstract] [Full Text] [Related]
49. Administrative and technical support of ambulatory infusional cancer chemotherapy (ICC). Moore C; Strong D J Infus Chemother; 1996; 6(4):161-3. PubMed ID: 9229310 [TBL] [Abstract][Full Text] [Related]
51. Pharmacist as a provider of oncology ambulatory care services. See K; Bergquist S Am J Hosp Pharm; 1976 Nov; 33(11):1145-7. PubMed ID: 998630 [TBL] [Abstract][Full Text] [Related]
52. [Chemotherapy (low-dose CDDP + UFT) to advanced pancreatic cancer in an ambulatory setting improved survival and quality of life]. Kitagawa H; Yoshizumi T; Morita A; Ohta T; Kayahara M; Nishimura G; Fujimura T; Shimizu K; Miwa K Gan To Kagaku Ryoho; 2001 Oct; 28(11):1684-7. PubMed ID: 11708009 [TBL] [Abstract][Full Text] [Related]
53. Outpatient chemotherapy administration: decreasing wait times for patients and families. Hendershot E; Murphy C; Doyle S; Van-Clieaf J; Lowry J; Honeyford L J Pediatr Oncol Nurs; 2005; 22(1):31-7. PubMed ID: 15574724 [TBL] [Abstract][Full Text] [Related]
55. [60 cases of advanced cancer treated by an association of ambulatory cytostatics during 1 to 4 years. Collaborational hospital consultation and doctors in charge of the cases]. Israel L; Depierre A Therapeutique; 1970 Apr; 46(4):415-7. PubMed ID: 4987709 [No Abstract] [Full Text] [Related]
56. Mastering chemotherapy dose reduction in elderly cancer patients. Wildiers H Eur J Cancer; 2007 Oct; 43(15):2235-41. PubMed ID: 17686626 [TBL] [Abstract][Full Text] [Related]
57. Impact of quality management monitoring and intervention on central venous catheter dysfunction in the outpatient chemotherapy infusion setting. Bansal A; Binkert CA; Robinson MK; Shulman LN; Pellerin L; Davison B J Vasc Interv Radiol; 2008 Aug; 19(8):1171-5. PubMed ID: 18656009 [TBL] [Abstract][Full Text] [Related]